Clinical trials: Pharmacist
Diabetes Mellitus Type 2
Bridging the Gap by Transitional Care
The purpose of the study is to evaluate patient adherence with discharge diabetes medications up to 120 days following pharmacist counseling during hospital stay about diabetes self management
- Trial name
- NCT01330121
- Testing
- Pharmacist Counseling
- Where
- United States
- Volunteers
- 130 people
- Sponsor
- Cook County Health
Heart Failure With Reduced Ejection Fraction
EHR Nudges to Improve Quality of Care in HF
The purpose of this pilot feasibility study is to test a pharmacist-facing clinical decision support tool designed to increase adherence to guideline-directed medical therapy and evaluate the tool using the Reach, Effectiveness…
- Trial name
- NCT06103565
- Testing
- Clinical Decision Support Tool
- Where
- United States
- Volunteers
- 3 people
- Sponsor
- Northwestern University
Drug Related Problem
Incidence and Risk Factor of Drug Related Problem Detected in Inpatient
Drug Related Problem (DRP) is defined as an event that may potentially affect the health outcomes in the patients. DRPs can occur at all stages of the medication usage process starting from prescribing to dispensing stage.
- Trial name
- DRPINPAT (NCT03476733)
- Testing
- Detection of drug related problem in inpatient
- Where
- France
- Volunteers
- 20,000 people
- Sponsor
- University Hospital, Montpellier
Medication Therapy Management
A Collaborative Approach to Medication Reviews for Older Patients With Polypharmacy
In patients aged 65 years and older, polypathology is frequent and often associated with polypharmacy. This polypharmacy may be a source of iatrogeny due to pharmacokinetic interactions, enhanced sensitivity of older people to…
- Trial name
- BIMEDOC (NCT03909035)
- Testing
- Medication therapy management
- Where
- France
- Volunteers
- 697 people
- Sponsor
- University Hospital, Toulouse
Pharmacogenomics, Medication Therapy Management
A Pharmacist Implemented Pharmacogenomics Service in the Program of All-inclusive Care for the Elderly
The aim of this study is to evaluate and describe the feasibility of implementing a pharmacist-led pharmacogenomics service for the Program of All-inclusive Care for the Elderly (PACE), a community-based practice setting.
- Trial name
- PACE (NCT03257605)
- Volunteers
- 296 people
- Sponsor
- Tabula Rasa HealthCare
Anticoagulants, Intention
Pharmacists' Intervention in Patients Using Novel Oral Anticoagulants：A Study on Behavioral Patterns
Novel oral anticoagulant drugs (NOACs) are now increasingly used in clinical practice. Although there are outstanding advantages of NOACs, there are also some shortcomings in use.
- Conditions
- Anticoagulants, Intention, Behavioral Symptoms
- Trial name
- NCT03670446
- Testing
- Pharmacists' intervention
- Where
- 2 sites in China
- Volunteers
- 400 people
- Sponsor
- Cui Yimin
Cardiovascular Risk Factor
Pharmacist Enhanced Service for Cardiovascular Risk Reduction
Pharmacist services such as medication review, counselling and treatment adherence clinics can improve clinical, health related quality of life and economic outcomes.
- Trial name
- NCT04220788
- Testing
- Enhanced pharmacist service, Usual care
- Where
- Malaysia
- Sponsor
- Monash University
Anticoagulants, Atrial Fibrillation
Improving Anticoagulation Control in VISN 1
Over 100,000 VHA patients receive anticoagulants (blood thinners) each year to prevent blood clots (including strokes). Too much anticoagulation increases the risk of serious or even fatal bleeding, and too little anticoagulation…
- Conditions
- Anticoagulants, Atrial Fibrillation, Venous Thromboembolism
- Trial name
- NCT01653405
- Testing
- Multifaceted behavioral intervention
- Where
- United States
- Volunteers
- 1,260,576 people
- Sponsor
- VA Office of Research and Development
Smoking Cessation, Tobacco Use Disorder
Engaging Pharmacists to Advance Tobacco Treatment Service Delivery
This research will test the effects of a novel program (ENHANCE-TTS) with tools, training, and clinic facilitation support that capitalizes on pharmacists' roles by expanding their scope of practice to deliver tobacco treatment.
- Conditions
- Smoking Cessation, Tobacco Use Disorder, Smoking, HIV
- Trial name
- NCT07501624
- Testing
- ENgaging pHarmacists to AdvANCE Tobacco Treatment Service delivery (ENHANCE-TTS)
- Where
- United States
- Volunteers
- 172 people
- Sponsor
- Medical University of South Carolina
Advanced or Metastatic Solid Tumor, Relapsed Hematologic Malignancy
Impact of the Coordinated Intervention of the Healthcare Facilities Pharmacist and the Dispensary Pharmacist on the Care Pathway for Cancer Patients Treated With Oral Therapy
The rise of oral therapies in the management of cancers has considerably changed the patient care path. If the oral route is preferred by patients because it offers a better quality of life, it is not without impact for patients…
- Trial name
- IPPACTTO (NCT04327583)
- Testing
- IPPACTTO
- Where
- 7 sites in France
- Volunteers
- 396 people
- Sponsor
- Institut Cancerologie de l'Ouest
Osteoporosis
Physician-Pharmacist Collaboration for Osteoporotic Patient Follow-up
The purpose of this study is to evaluate the follow-up of the osteoporotic patient by a physician-pharmacist collaboration.
- Trial name
- SIOUX (NCT02892188)
- Where
- France
- Volunteers
- 120 people
- Sponsor
- Centre Hospitalier Régional Metz-Thionville
Atrial Fibrillation
AIHEMAF - P "An Innovative Healthcare Model for AF Patients"
Non-profit observational study on the role of the community pharmacist and "the pharmacy of services" in the case management of patients suffering from atrial fibrillation and being treated with new generation oral anticoagulants
- Trial name
- AIHEMAF - P (NCT05086991)
- Testing
- Follow up
- Where
- Italy
- Volunteers
- 50 people
- Sponsor
- Farmacia La Regina s.r.l.
Hiv
Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs
This study addresses real-world use of long-acting injectable cabotegravir/rilpivirine (CAB/RPV LA) by evaluating implementation and clinical outcomes of a pharmacist-led collaborative drug therapy management model (CDTM+) that…
- Trial name
- NCT06411223
- Testing
- Collaborative drug therapy management model, Cabotegravir/Rilpivirine
- Where
- United States
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Yale University
Opioid Use Disorder, Overdose
Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD)
The purpose of this study is to investigate the impact of a pharmacist-led intervention to expand access to medications for opioid use disorder (MOUD) on racial/ethnic differences in opioid-related overdose among individuals…
- Trial name
- PLI-MOUD (NCT05776823)
- Testing
- Pharmacist Narcan Training, BIRT, SMC
- Where
- United States
- Volunteers
- 267 people
- Sponsor
- University of Arkansas
Depression, Antidepressant
Studying the Impact of Medication Counselling by Community Pharmacists in Patients Starting a Treatment With Antidepressants
The objective of the SIMCA study was to analyse the impact of structured medication counselling by community pharmacists on medication adherence, economic, clinical and humanistic outcomes of depressed primary care patients who…
- Trial name
- SIMCA (NCT02187380)
- Where
- Belgium
- Volunteers
- 223 people
- Sponsor
- KU Leuven
Pneumococcal Pneumonia
Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain
The goals of the study are to determine the pneumococcal polysaccharide vaccination rate in patients with diabetes before and after community pharmacist education and intervention.
- Trial name
- NCT03851978
- Testing
- Pharmacist Vaccine Education
- Where
- 4 sites in United States
- Volunteers
- 431 people, healthy volunteers welcome
- Sponsor
- Virginia Commonwealth University
Readmission, Hospital
Post-Discharge Follow-Up Phone Call by a Pharmacist and Impact on Patient Care
The purpose is to analyze whether a follow-up telephone call by a pharmacist after patient discharge from the hospital can improve patient outcomes.
- Trial name
- NCT00332514
- Testing
- telephone call by a pharmacist
- Where
- United States
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Boston Medical Center
Coronary Artery Disease
The Role of Clinical Pharmacist in Monitoring Drug Therapy in the Cardiovascular and Coronary Care Units in Libya.
Assessment of role of clinical pharmacist in decreasing morbidity and mortality among coronary artery disease patients.
- Trial name
- BSU (NCT05531552)
- Testing
- clinical pharmacy application
- Where
- Egypt
- Volunteers
- 100 people
- Sponsor
- Beni-Suef University
Neoplasm
Evaluation of the Impact of the Clinical Pharmacist in Oral Therapies in Oncology.
The hospital pharmacist plays a vital role at the time of the patient's first prescription in a healthcare facility, to inform the patient about his or her new therapy and create a link between the hospital and the patient's home…
- Trial name
- PHARMAIMPACT2 (NCT06980012)
- Testing
- Pharmaceutical consultation, Pharmaceutical consultation and follow-up
- Where
- France
- Volunteers
- 90 people
- Sponsor
- Polyclinique Lyon Nord
Medication Compliance
mHealth Medication Safety Intervention
TRANSAFE Rx is a 12-month, parallel two-arm, 1:1 randomized controlled clinical trial, involving 136 participants (68 in each arm) measuring the clinical and economic effectiveness of a pharmacist-led intervention, which utilizes…
- Trial name
- NCT03247322
- Testing
- Pharmacist-led medication therapy using mHealth application
- Where
- United States
- Volunteers
- 136 people
- Sponsor
- Medical University of South Carolina